autologous dendritic cell vaccination

BIOLOGICAL3 trials

Sponsors

Radboud University Medical Center, University Hospital, Antwerp, Clinica Universidad de Navarra, Universidad de Navarra

Conditions

Breast CancersColorectal TumorsGlioblastomaMalignant MesotheliomaMelanomaRenal Cell CarcinomaSarcomasStage II Breast Cancer

Phase 1

Toll-like Receptor (TLR) Ligand Matured Dendritic Cell Vaccination in Melanoma Patients

CompletedNCT00940004

Radboud University Medical CenterMelanoma

Start: 2009-06-30End: 2014-11-30Updated: 2017-04-17

Dendritic Cell Vaccination for Patients with Solid Tumors

CompletedNCT01291420

University Hospital, AntwerpBreast Cancers, Colorectal Tumors, Glioblastoma +3

Start: 2010-05-03End: 2017-11-02Updated: 2024-12-09

Phase 2

Trial With Autologous Dendritic Cell Vaccination in Patients With Stage II-III HER2 Negative Breast Cancer

CompletedNCT01431196

Clinica Universidad de Navarra, Universidad de NavarraStage II Breast Cancer, Stage III Breast Cancer

Start: 2011-02-28End: 2013-12-31Updated: 2016-05-19

Related Papers

Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma—Protocol of the Immuno-MESODEC study

PLoS ONE2024-07-154 citations

Adjuvant Wilms’ tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium

BMJ Open2024-03-013 citations

Abstract P2-14-11: Immune response monitoring in breast cancer patients treated with neoadjuvant chemotherapy combined with dendritic cell vaccines

Cancer Research2022-02-151 citations

Impact of dendritic cell vaccines added to neoadjuvant CT on pathological complete responses in early breast cancer patients according to PD-L1 expression.

Journal of Clinical Oncology2021-05-204 citations

Final results regarding the addition of dendritic cell vaccines to neoadjuvant chemotherapy in early HER2-negative breast cancer patients: clinical and translational analysis

Therapeutic Advances in Medical Oncology2021-01-0127 citations

Abstract P2-04-01: Increased stromal lymphocytes in breast cancer patients with autologous dendritic cell vaccination plus neoadjuvant chemotherapy

Cancer Research2017-02-15

Impact of CD8 stromal lymphocytes in BC patients with the addition of autologous dendritic CELL vaccination to neoadjuvant chemotherapy.

Journal of Clinical Oncology2016-05-202 citations

Dendritic cell vaccination in malignant pleural mesothelioma: A phase I/II study.

Journal of Clinical Oncology2014-05-2013 citations